Gilead to license hepatitis C drug to lower-cost manufacturers in India MSN Money The Foster City, California-based company has said the price is fair because the treatment offers a potential cure for the liver-destroying virus without injections of interferon, which can cause severe side effects that compromise patient outcomes ... |
